# RCT Study on the Therapeutic Effect of Escitalopram Loaded With XingpiJieyu Formula on Resting State EEG Energy Abnormalities in Severe Liver Depression and Spleen Deficiency Type MDD

> **NCT06758167** · NA · COMPLETED · sponsor: **Peking University Sixth Hospital** · enrollment: 150 (actual)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** XingpiJieyu formula
- **DRUG:** Placebo
- **DRUG:** Escitalopram

## Key facts

- **NCT ID:** NCT06758167
- **Lead sponsor:** Peking University Sixth Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-14
- **Primary completion:** 2024-04-02
- **Final completion:** 2024-04-02
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06758167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06758167, "RCT Study on the Therapeutic Effect of Escitalopram Loaded With XingpiJieyu Formula on Resting State EEG Energy Abnormalities in Severe Liver Depression and Spleen Deficiency Type MDD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06758167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*